Skip to main content
HR 1796 119th Congress House Health Blood and blood diseases Genetics Health promotion and preventive care Hereditary and development disorders Medical research Research administration and funding

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Introduced: March 3, 2025 Introduced by: James, John Republican · Michigan See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 3, 2025
Introduced in House
Mar 3, 2025
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now March 3, 2025

Referred to the House Committee on Energy and Commerce.

 Related & companion bills 4
  • HR 7148 Related bill Consolidated Appropriations Act, 2026
  • S 891 Related bill Bipartisan Health Care Act
  • S 735 Identical bill Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
  • HR 1768 Related bill Lower Costs for Everyday Americans Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 24

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • ARTEMIS POLICY GROUP LLC
    for SICKLE CELL DISEASE ASSOCIATION OF AMERICA · Maryland · 1st Quarter (Jan 1 - Mar 31) 2026
  • THE MCMANUS GROUP
    for FULCRUM THERAPEUTICS · Massachusetts · 1st Quarter (Jan 1 - Mar 31) 2026
  • TERUMO BCT, INC.
    for TERUMO BCT, INC. · Colorado · 1st Quarter (Jan 1 - Mar 31) 2026
  • OGR
    for LEAVITT PARTNERS, LLC ON BEHALF OF SICKLE CELL DISEASE PARTNERSHIP · Michigan · 1st Quarter (Jan 1 - Mar 31) 2026
  • INDIGO HILL STRATEGIES
    for SICK CELLS · Illinois · 1st Quarter (Jan 1 - Mar 31) 2026
  • ARTEMIS POLICY GROUP LLC
    for SICKLE CELL DISEASE ASSOCIATION OF AMERICA · Maryland · 4th Quarter (Oct 1 - Dec 31) 2025
See all 24 filings →
 Cosponsors 6
All 6 Democratic 5 Republican 1
D
Bishop, Sanford D.
Georgia · Jan 16, 2026
 D
Vindman, Eugene Simon
Virginia · Aug 15, 2025
 D
Carter, Troy A.
Louisiana · Mar 3, 2025
 D
Davis, Danny K.
Illinois · Mar 3, 2025
 R
Kiggans, Jennifer A.
Virginia · Mar 3, 2025
 D
Veasey, Marc A.
Texas · Mar 3, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1796: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-1796/
MLA
"H.R. 1796: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-1796/.
Bluebook (legal)
H.R. 1796, 119th Cong. (2026), https://openamerica.io/bill/119-HR-1796/.
Markdown link
[H.R. 1796: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025](https://openamerica.io/bill/119-HR-1796/)
Report a problem